Morepen Laboratories Ltd consolidated Q1 FY26 PAT lower at Rs. 11.40 crore

Morepen Laboratories Limited has reported Consolidated financial results for the period ended June 30, 2025.

Financial Results (Q1 FY2026) - QoQ Comparison

The company has reported total income of Rs. 429.6473 crores during the period ended June 30, 2025 as compared to Rs. 470.4647 crores during the period ended March 31, 2025.

The company has posted net profit / (loss) of Rs. 11.4066 crores for the period ended June 30, 2025 as against net profit / (loss) of Rs. 20.3104 crores for the period ended March 31, 2025.

The company has reported EPS of Rs. 0.20 for the period ended June 30, 2025 as compared to Rs. 0.35 for the period ended March 31, 2025.

Financials	Q1 FY2026	Q4 FY2025	% Change
Total Income	₹ 429.6473 crs	₹470.4647 crs	-8.68%
Net Profit	₹11.4066 crs	₹20.3104 crs	-43.84%
EPS	₹0.20	₹0.35	-42.86%

Financial Results (Q1 FY2026) - YoY Comparison

The company has reported total income of Rs. 429.6473 crores during the period ended June 30, 2025 as compared to Rs.458.6427 crores during the period ended June 30, 2024.

The company has posted net profit / (loss) of Rs.11.4066 crores for the period ended June 30, 2025 as against net profit / (loss) of Rs.36.1679 crores for the period ended June 30, 2024.

The company has reported EPS of Rs.0.20 for the period ended June 30, 2025 as compared to Rs.0.71 for the period ended June 30, 2024.

Financials	Q1 FY2026	Q1 FY2025	% Change
Total Income	₹ 429.6473 crs	₹458.6427 crs	-6.32%
Net Profit	₹11.4066 crs	₹36.1679 crs	-68.46%
EPS	₹0.20	₹0.71	-71.83%

Shares of Morepen Laboratories Limited was last trading in BSE at Rs. 53.25 as compared to the previous close of Rs. 56.56. The total number of shares traded during the day was 738924 in over 6378 trades.

The stock hit an intraday high of Rs. 57.28 and intraday low of 51.75. The net turnover during the day was Rs. 40277862.00.

Source : Equity Bulls

Keywords

MorepenLaboratories Q1FY26 Q1FY2026 FY2026 ResultUpdate